Skeletal effects of estrogen analogs

Osteoporosis International

Volumn 7, Issue SUPPL. 1, 1997, Pages 40-42

  Lindsay, R ^a   Cosman, F ^a  

^a HELEN HAYES HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE ACETATE; OD 14; OSTEOCALCIN; RALOXIFENE; TAMOXIFEN; TIBOLONE; UNCLASSIFIED DRUG;

BONE ATROPHY; BONE CELL; BONE MASS; BONE REMODELING; BREAST CANCER; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HOMEOSTASIS; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0030944869     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01674812     Document Type: Conference Paper

References (22)

1. Albright F, Bloomberg F, Smith PH. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940;55:298-305.
2. Lindsay R. The menopause and osteoporosis. Obstet Gynecol 1996;87:16S-19S.
3. Cosman F, Dempster D, Lindsay R. Clinical effects of estrogens and anti-estrogens on the skeleton and skeletal metabolism. In: Lindsay R, Dempster DW, Jordan CV (eds) Estrogens and anti-estrogens: Basic and Clinical Aspects. Lippincott-Raven, 1997, in press
4. Lindsay R. Estrogen deficiency. In: Riggs BL, Melton LJ, editorss. Osteoporosis: etiology,diagnosis and management. Philadelphia: Lippincott-Raven. 1995:133-60.
5. Seibel MJ, Cosman F, Shen V, et al. Urinary hydroxypyridinium crosslinks of collagen are markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner 1993;8:881-9.
6. Paganini-Hill A, Ross RK, Gerkins VR, et al. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981;95:28-31.
7. Lindsay R. Estrogens, bone mass, and osteoporotic fracture. Am J Med 1991;91:5B-10S-13S.
8. Gallagher JC, Kable WT, Goldgar D. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 1991;90:171-8.
9. Abdalla HI, Hart DM, Lindsay R, Beastall GH. Organon OD-14 (Tibolone) and menopausal dynamic hormone profiles. Maturitas 1986;8:81-5.
10. Raisz LG, Wiita B, Artis A, et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endrocrinol Metab 1996;81:37-43.
11. Love RR, Mazess RB, Tormey DC, et al. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat 1988;12:297-301.
12. Turkin S, Sins E, Seldin D, et al. Effects of tamoxifen on spinal bone density in women with breast cancer. J Natl Cancer Inst 1989;71:1086-8.
13. Fentiman IS, Saad Z, Caleffi M, et al. Tamoxifen protects against steroid induced bone loss. Eur J Cancer 1992;28:684-5.
14. Love RR, Mazess RB, Barden HS, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992;326:852-6.
15. Knstensen B, Ejlertsen B, Dalgaar P, et al. Tamoxifen and bone metabolism in postmenopausal low risk breast cancer patients: a randomized study. J Clin Oncol 1994;12:992-7.
16. Kapikian AZ, Goldberg KM, Knowlton DR, et al. Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women. Bone Miner 1993;22:87-94.
17. Grey AB, Stapleton JP, Evans MC, et al. The effect of anti-estrogen tamoxifen on bone mineral density in normal late postmenopausal women. Am J Med 1995;99:636-41.
18. Powles TJ, Hickish T, Kanis JA, et al. Effect of tamoxifen on bone mineral density measured by dual energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 1996;14:78-84.
19. Wright CDP, Mansel RE, Gazet JC, et al. Effect of long term tamoxifen treatment on bone turnover in women with breast cancer. BMJ 1993;306:429-30.
20. Draper MW, Flowers DE, Huster WJ, et al. A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy, postmenopausal women. J Bone Miner Res 1996;11:835-42.
21. Cosman F, Nieves J, Sherwood D, et al. Comparative effects of tissue selective estrogens and estrogen on bone mineral turnover. J Bone Miner Res 1996,11:S450.
22. Heaney RP, Draper MW. Raloxifene mimics estrogen in human bone remodelling kenetics. J Bone Miner Res 1996;11:S446.